Individuals of both genders bearing harmful BRCA1 or BRCA2 variants face augmented risks of pancreatic cancer, albeit the degree of risk elevation is comparatively modest [23–25]. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.